Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
125.1 USD | +3.01% |
|
+7.81% | +25.83% |
15/07 | Moderna Insider Sold Shares Worth $1,756,177, According to a Recent SEC Filing | MT |
12/07 | China approves CSPC Pharma's RSV vaccine for clinical trials | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.83% | 4.8TCr | |
+45.38% | 4.15TCr | |
+0.69% | 4.24TCr | |
+30.52% | 3.16TCr | |
+22.30% | 2.86TCr | |
-6.35% | 2.8TCr | |
+49.25% | 1.46TCr | |
+49.18% | 1.41TCr | |
+3.45% | 1.26TCr | |
-3.85% | 1.17TCr |
- Stock Market
- Equities
- MRNA Stock
- News Moderna, Inc.
- UBS Adjusts Moderna Price Target to $151 From $143, Maintains Buy Rating